Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
1,565 nm NAFL, Isotretinoin, and PBT for Acne Vulgaris
NCT04156815Completed
- Start
- Jul 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of isotretinoin in acne vulgaris (4 arms). Primary endpoints: Visia CR imaging system assessment at 24 weeks and Antera3D system assessment at 24 weeks. Started Jul 2018; status: completed.
02
Drugs
isotretinoin
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT04156815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156815.